Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 96

Sort by

Sort Order Select

Journal Articles

DNA Methylation and Genetic Profiles in 320 Patients with Myelodysplastic Syndromes

Blood (2018) 132 (Supplement 1): 1799.

https://doi.org/10.1182/blood-2018-99-116489

Published: 2018

Journal Articles

Excess Coincidences of Hematopoietic Neoplasms

Dominic Rose, PhD, Tamara Alpermann, Claudia Haferlach, MD, Torsten Haferlach, Wolfgang Kern, MD

Blood (2015) 126 (23): 2688.

https://doi.org/10.1182/blood.V126.23.2688.2688

Published: 2015

Journal Articles

Myelodysplastic Syndrome Patients Show Mutation-Specific DNA Methylation Patterns

Constance Regina Baer, PhD, Niroshan Nadarajah, M.Sc., Yasunobu Nagata, MD, Tamara Alpermann, Genta Nagae, MD PhD, Yusuke Okuno, MD PhD, Yuichi Shiraishi, MD PhD, Satoru Miyano, MD PhD, Claudia Haferlach, MD, Wolfgang Kern, MD, Hiroyuki Aburatani, MD PhD, Seishi Ogawa, MD PhD, Torsten Haferlach

Blood (2015) 126 (23): 1646.

https://doi.org/10.1182/blood.V126.23.1646.1646

Published: 2015

Journal Articles

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

Blood (2015) 126 (23): 5205.

https://doi.org/10.1182/blood.V126.23.5205.5205

Published: 2015

Journal Articles

Higher Percentages of Ring Sideroblasts and SF3B1 Mutations in Patients with AML Correlate with Mutations in TP53 and Adverse Cytogenetics, but Have No Independent Impact on Outcome

Pedro Martin-Cabrera, MD, Sabine Jeromin, PhD, Tamara Alpermann, Karolína Perglerová, Claudia Haferlach, MD, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 3847.

https://doi.org/10.1182/blood.V126.23.3847.3847

Published: 2015

Journal Articles

Abnormalities Detected By Array CGH and Fluorescence in Situ Hybridization in AML with Normal Karyotype Lacking Mutations in NPM1 , CEBPA , RUNX1 and MLL Partial Tandem Duplications Are Associated with Unfavorable Outcome

Claudia Haferlach, MD, Kathleen Zieschang, Susanne Schnittger, PhD, Tamara Alpermann, Melanie Zenger, Karolína Perglerová, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 1371.

https://doi.org/10.1182/blood.V126.23.1371.1371

Published: 2015

Journal Articles

Prognosis of Mecom(EVI1)- rearranged MDS and AML Patients Strongly Depends on Accompanying Molecular Mutations but Not on Blast Counts

Tamara Alpermann, Claudia Haferlach, MD, Annette Fasan, PhD, Sonja Schindela, Wolfgang Kern, MD, Torsten Haferlach

Blood (2015) 126 (23): 1372.

https://doi.org/10.1182/blood.V126.23.1372.1372

Published: 2015

Journal Articles

BAALC Expression Is a Feasible Marker for Risk Stratification and Detection of Minimal Residual Disease in Cytogenetically Normal Acute Myeloid Leukemia

Simone Weber, Tamara Alpermann, Karolína Perglerová, Susanne Schnittger, PhD, Torsten Haferlach, Claudia Haferlach, MD, Wolfgang Kern, MD

Blood (2015) 126 (23): 1373.

https://doi.org/10.1182/blood.V126.23.1373.1373

Published: 2015

Journal Articles

Modulation of the Clonal Composition in Relapsed CLL: A Study Based on Targeted Deep-Sequencing of ATM, BIRC3, NOTCH1, POT1, SF3B1, SAMHD1 and TP53

Sabine Jeromin, PhD, Wolfgang Kern, MD, Richard Schabath, Tamara Alpermann, Niroshan Nadarajah, M.Sc., Manja Meggendorfer, PhD, Susanne Schnittger, PhD, Torsten Haferlach, Claudia Haferlach, MD

Blood (2015) 126 (23): 1721.

https://doi.org/10.1182/blood.V126.23.1721.1721

Published: 2015

Journal Articles

Two Novel Distinct Subtypes of Myeloid Neoplasms Molecularly Associated with Histone H3K36 Methylations

Blood (2015) 126 (23): 2841.

https://doi.org/10.1182/blood.V126.23.2841.2841

Published: 2015

Journal Articles

Profiling of somatic mutations in acute myeloid leukemia with FLT3 -ITD at diagnosis and relapse

Blood (2015) 126 (22): 2491–2501.

https://doi.org/10.1182/blood-2015-05-646240

Published: 2015

Includes: Supplemental data

Journal Articles

In AML Secondary to MDS NPM1 Mutations Are Late Events, Less Frequent, and Associated with a Different Pattern of Molecular Mutations Than in De Novo AML

Susanne Schnittger, PhD, Claudia Haferlach, MD, Niroshan Nadarajah, M.Sc., Tamara Alpermann, Manja Meggendorfer, PhD, Karolina Perglerová, Wolfgang Kern, MD, Torsten Haferlach

Blood (2014) 124 (21): 700.

https://doi.org/10.1182/blood.V124.21.700.700

Published: 2014

Journal Articles

Molecular Analysis of Myelodysplastic Syndrome with Isolated Del(5q) Reveals a Broad Spectrum of Clinically Relevant Mutations: A Study on 119 Patients and 26 Genes

Manja Meggendorfer, PhD, Tamara Alpermann, Claudia Haferlach, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach

Blood (2014) 124 (21): 4608.

https://doi.org/10.1182/blood.V124.21.4608.4608

Published: 2014

Journal Articles

Development of Molecular Mutations during the Evolution of Therapy-Related MDS and Therapy-Related AML

Wolfgang Kern, MD, Manja Meggendorfer, PhD, Tamara Alpermann, Andreia de Albuquerque, PhD, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2014) 124 (21): 4624.

https://doi.org/10.1182/blood.V124.21.4624.4624

Published: 2014

Journal Articles

In CML Patients with Good Response to TKIs Other Gene Mutations Are Frequently (37%) Present in Addition to Philadelphia Negative, Cytogenetically Aberrant Clones but Are Rare (4%) in Cases with MMR and Normal Karyotype

Susanne Schnittger, PhD, Manja Meggendorfer, PhD, Niroshan Nadarajah, M.Sc., Tamara Alpermann, Wolfgang Kern, MD, Torsten Haferlach, Claudia Haferlach, MD

Blood (2014) 124 (21): 3126.

https://doi.org/10.1182/blood.V124.21.3126.3126

Published: 2014

Journal Articles

Comprehensive Molecular Analyses of BCR-ABL1 Negative MPN Show That PMF Is Genetically Much More Heterogeneous Than ET and PV

Manja Meggendorfer, PhD, Tamara Alpermann, Claudia Haferlach, MD, Wolfgang Kern, MD, Susanne Schnittger, PhD, Torsten Haferlach, MD

Blood (2014) 124 (21): 3224.

https://doi.org/10.1182/blood.V124.21.3224.3224

Published: 2014

Journal Articles

CML Patients with Resistance to Tyrosine Kinase Inhibitors and without BCR-ABL1 Resistance Mutation Frequently Carry Other Gene Mutations

Susanne Schnittger, PhD, Claudia Haferlach, MD, Niroshan Nadarajah, M.Sc., Manja Meggendorfer, PhD, Annette Fasan, PhD, Dominic Rose, PhD, Tamara Alpermann, Wolfgang Kern, MD, Torsten Haferlach

Blood (2014) 124 (21): 4516.

https://doi.org/10.1182/blood.V124.21.4516.4516

Published: 2014

Journal Articles

Genetic Patterns of Relapsed AML Differ Significantly from First Manifestation and Are Dependent on Cytogenetic Risk Groups at Diagnosis: Results in 175 Patients with Paired Samples

Manja Meggendorfer, PhD, Tamara Alpermann, Karolina Perglerová, Wolfgang Kern, MD, Susanne Schnittger, PhD, Claudia Haferlach, MD, Torsten Haferlach

Blood (2014) 124 (21): 1029.

https://doi.org/10.1182/blood.V124.21.1029.1029

Published: 2014

Journal Articles

DNMT3A is a Powerful Follow-up Marker in NPM1 mutated AML

Susanne Schnittger, PhD, Claudia Haferlach, MD, Tamara Alpermann, Niroshan Nadarajah, M.Sc., Manja Meggendorfer, PhD, Karolina Perglerová, Wolfgang Kern, MD, Torsten Haferlach

Blood (2014) 124 (21): 122.

https://doi.org/10.1182/blood.V124.21.122.122

Published: 2014

Journal Articles

Cytogenetic and Molecular Genetic Shifts in 27 Genes Investigated By NGS Depict Specific Routes from MDS to s-AML in 38 Patients with Paired Samples

Andreia De Albuquerque, PhD, Manja Meggendorfer, PhD, Wolfgang Kern, MD, Karolina Perglerová, Tamara Alpermann, Claudia Haferlach, MD, Susanne Schnittger, PhD, Torsten Haferlach

Blood (2014) 124 (21): 2378.

https://doi.org/10.1182/blood.V124.21.2378.2378

Published: 2014

NARROW

DNA Methylation and Genetic Profiles in 320 Patients with Myelodysplastic Syndromes

Excess Coincidences of Hematopoietic Neoplasms

Myelodysplastic Syndrome Patients Show Mutation-Specific DNA Methylation Patterns

Landscape of DNA Methylation and Genetic Profiles in 291 Patients with Myelodysplastic Syndromes

Higher Percentages of Ring Sideroblasts and SF3B1 Mutations in Patients with AML Correlate with Mutations in TP53 and Adverse Cytogenetics, but Have No Independent Impact on Outcome

Abnormalities Detected By Array CGH and Fluorescence in Situ Hybridization in AML with Normal Karyotype Lacking Mutations in NPM1 , CEBPA , RUNX1 and MLL Partial Tandem Duplications Are Associated with Unfavorable Outcome

Prognosis of Mecom(EVI1)- rearranged MDS and AML Patients Strongly Depends on Accompanying Molecular Mutations but Not on Blast Counts

BAALC Expression Is a Feasible Marker for Risk Stratification and Detection of Minimal Residual Disease in Cytogenetically Normal Acute Myeloid Leukemia

Modulation of the Clonal Composition in Relapsed CLL: A Study Based on Targeted Deep-Sequencing of ATM, BIRC3, NOTCH1, POT1, SF3B1, SAMHD1 and TP53

Two Novel Distinct Subtypes of Myeloid Neoplasms Molecularly Associated with Histone H3K36 Methylations

Profiling of somatic mutations in acute myeloid leukemia with FLT3 -ITD at diagnosis and relapse

In AML Secondary to MDS NPM1 Mutations Are Late Events, Less Frequent, and Associated with a Different Pattern of Molecular Mutations Than in De Novo AML

Molecular Analysis of Myelodysplastic Syndrome with Isolated Del(5q) Reveals a Broad Spectrum of Clinically Relevant Mutations: A Study on 119 Patients and 26 Genes

Development of Molecular Mutations during the Evolution of Therapy-Related MDS and Therapy-Related AML

In CML Patients with Good Response to TKIs Other Gene Mutations Are Frequently (37%) Present in Addition to Philadelphia Negative, Cytogenetically Aberrant Clones but Are Rare (4%) in Cases with MMR and Normal Karyotype

Comprehensive Molecular Analyses of BCR-ABL1 Negative MPN Show That PMF Is Genetically Much More Heterogeneous Than ET and PV

CML Patients with Resistance to Tyrosine Kinase Inhibitors and without BCR-ABL1 Resistance Mutation Frequently Carry Other Gene Mutations

Genetic Patterns of Relapsed AML Differ Significantly from First Manifestation and Are Dependent on Cytogenetic Risk Groups at Diagnosis: Results in 175 Patients with Paired Samples

DNMT3A is a Powerful Follow-up Marker in NPM1 mutated AML

Cytogenetic and Molecular Genetic Shifts in 27 Genes Investigated By NGS Depict Specific Routes from MDS to s-AML in 38 Patients with Paired Samples

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only